Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Transcriptomic signature of Bexarotene (Rexinoid LGD1069) on mammary gland from three transgenic mouse mammary cancer models

  • Martin C Abba1, 4,
  • Yuhui Hu1,
  • Carla C Levy1,
  • Sally Gaddis1,
  • Frances S Kittrell2,
  • Yun Zhang2,
  • Jamal Hill2,
  • Reid P Bissonnette3,
  • Daniel Medina2,
  • Powel H Brown2 and
  • C Marcelo Aldaz1Email author
BMC Medical Genomics20081:40

DOI: 10.1186/1755-8794-1-40

Received: 22 May 2008

Accepted: 11 September 2008

Published: 11 September 2008

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
22 May 2008 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
22 Jul 2008 Author responded Author comments - C. Marcelo Aldaz
Resubmission - Version 4
22 Jul 2008 Submitted Manuscript version 4
26 Aug 2008 Reviewed Reviewer Report - Jeff Green
28 Aug 2008 Reviewed Reviewer Report - Jose Luis Costa
5 Sep 2008 Author responded Author comments - C. Marcelo Aldaz
Resubmission - Version 5
5 Sep 2008 Submitted Manuscript version 5
Publishing
11 Sep 2008 Editorially accepted
11 Sep 2008 Article published 10.1186/1755-8794-1-40

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Carcinogenesis, Science Park-Research Division, The University of Texas M.D. Anderson Cancer Center
(2)
Breast Center, Departments of Medicine and Molecular and Cellular Biology, Baylor College of Medicine
(3)
Department of Molecular Oncology, Ligand Pharmaceuticals Inc.
(4)
CINIBA, Facultad de Ciencias Médicas, Universidad Nacional de La Plata

Advertisement